Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

Hiroshi Kataoka, Satoru Muto(Juntendo University), Fumihiko Hattanda(Hokkaido University), Kan Katayama(Mie University), Kengo Furuichi(Kanazawa Medical University), Tadashi Otsuka(Niigata University), Kenichiro Miura(Japanese Society for Dialysis Therapy), Toshio Mochizuki(Tokyo Women's Medical University), Eiji Ishikawa(Yokohama City University Hospital), Koichi Nakanishi(University of the Ryukyus), Yosuke Shimada(Juntendo University), Hirayasu Kai(University of Tsukuba), Ichiei Narita(Niigata University), Kazushige Hanaoka(Jikei University School of Medicine), Sumi Hidaka(Shonan Kamakura General Hospital), Shiho Makabe(Tokyo Women's Medical University), Hirokazu Okada(University of Tsukuba), Michihiro Mitobe(Ijinkai Takeda General Hospital), Shun Manabe(Tokyo Women's Medical University), Kiyotaka Uchiyama(Japanese Red Cross Medical Center), Takuya Fujimaru(Unknown), Tatsuya Suwabe(Toranomon Hospital), Mahiro Kurashige(Jikei University School of Medicine), Wataru Shimabukuro(University of the Ryukyus), Shinya Nakatani(Osaka City University), Akinari Sekine(Toranomon Hospital), Shigeo Horie(Juntendo University), Tomonori Kimura(University of New Mexico), Saori Nishio(Hokkaido University), Junichi Hoshino(Japanese Society for Dialysis Therapy), Hiroki Hayashi(Fujita Health University), Mai Sato(Kyoto University), Ken Tsuchiya(Tokyo Women's Medical University), Tomofumi Moriyama(Kurume University), Haruna Kawano(Juntendo University), Daisuke Ichikawa(University of Yamanashi Hospital), Koichi Seta(Rutgers, The State University of New Jersey), Keiji Shimazu(Saiseikai Nakatsu Hospital)
Clinical and Experimental Nephrology
June 27, 2023
Cited by 5


Related Papers